ESC Premium Access

CSK9 inhibitors and cardiovascular outcomes – Represented in New England Journal of Medicine by the FOURIER and SPIRE trials.

Congress Presentation

About the speaker

Professor Marc Sabatine

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
25 presentations
1 follower

3 more presentations in this session

Bioresorbable vascular scaffolds for PCI – Represented in New England Journal of Medicin by the ABSORB III and AIDA trials.

Speaker: Doctor J. Wykrzykowska (Groningen, NL)

Thumbnail

ICD implantation for non-ischaemic cardiomyopathy – Represented in New England Journal of Medicine by the DANISH trial.

Speaker: Professor L. Kober (Copenhagen, DK)

Thumbnail

Prevention of recurrent venous thromboembolism – Represented in New England Journal of Medicine by several trials, including EINSTEIN, AMPLIFY, WARFASA, Hokusai-VTE, and others.

Speaker: Doctor J. Weitz (Hamilton, CA)

Thumbnail

Access the full session

Highlights from the New England Journal of Medicine: editors’ choice

Speakers: Professor M. Sabatine, Doctor J. Wykrzykowska, Professor L. Kober, Doctor J. Weitz
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations